Marinus Pharmaceuticals Inc (MRNS)
1.49
-0.02
(-1.32%)
USD |
NASDAQ |
May 06, 16:00
1.49
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Revenue (TTM): 30.99M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.99M |
| September 30, 2023 | 30.96M |
| June 30, 2023 | 25.96M |
| March 31, 2023 | 21.67M |
| December 31, 2022 | 25.48M |
| September 30, 2022 | 19.84M |
| Date | Value |
|---|---|
| June 30, 2022 | 27.61M |
| March 31, 2022 | 27.72M |
| December 31, 2021 | 15.34M |
| September 30, 2021 | 15.37M |
| June 30, 2021 | 5.429M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
5.429M
Minimum
Jun 2021
30.99M
Maximum
Dec 2023
22.40M
Average
25.48M
Median
Dec 2022
Revenue (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | 131.31M |
| Soligenix Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Macrogenics Inc | 56.91M |
| ADMA Biologics Inc | 258.22M |